» Articles » PMID: 22376256

Alterations in Skeletal Muscle Indicators of Mitochondrial Structure and Biogenesis in Patients with Type 2 Diabetes and Heart Failure: Effects of Epicatechin Rich Cocoa

Abstract

(-)-Epicatechin (Epi), a flavanol in cacao stimulates mitochondrial volume and cristae density and protein markers of skeletal muscle (SkM) mitochondrial biogenesis in mice. Type 2 diabetes mellitus (DM2) and heart failure (HF) are diseases associated with defects in SkM mitochondrial structure/function. A study was implemented to assess perturbations and to determine the effects of Epi-rich cocoa in SkM mitochondrial structure and mediators of biogenesis. Five patients with DM2 and stage II/III HF consumed dark chocolate and a beverage containing approximately 100 mg of Epi per day for 3 months. We assessed changes in protein and/or activity levels of oxidative phosphorylation proteins, porin, mitofilin, nNOS, nitric oxide, cGMP, SIRT1, PGC1α, Tfam, and mitochondria volume and cristae abundance by electron microscopy from SkM. Apparent major losses in normal mitochondria structure were observed before treatment. Epi-rich cocoa increased protein and/or activity of mediators of biogenesis and cristae abundance while not changing mitochondrial volume density. Epi-rich cocoa treatment improves SkM mitochondrial structure and in an orchestrated manner, increases molecular markers of mitochondrial biogenesis resulting in enhanced cristae density. Future controlled studies are warranted using Epi-rich cocoa (or pure Epi) to translate improved mitochondrial structure into enhanced cardiac and/or SkM muscle function.

Citing Articles

Response of VO to dark chocolate consumption in healthy subjects: A systematic review and meta-analysis of randomized controlled trials.

Mehdipour A, Saedmocheshi S, Stefani G, Amiri E, Heidary D Physiol Rep. 2025; 13(5):e70256.

PMID: 40000922 PMC: 11859664. DOI: 10.14814/phy2.70256.


Protective Role of (-)-Epicatechin on Trimethylamine-N-Oxide (TMAO)-Induced Cardiac Hypertrophy via SP1/SIRT1/SUMO1 Signaling Pathway.

Hong S, Lu J, Li J, Luo Y, Liu D, Jin Y Cardiovasc Toxicol. 2024; 24(12):1335-1347.

PMID: 39419946 PMC: 11564365. DOI: 10.1007/s12012-024-09932-8.


Mitochondria in Retinal Ganglion Cells: Unraveling the Metabolic Nexus and Oxidative Stress.

Yang T, Kang E, Lin P, Yu B, Wang J, Chen V Int J Mol Sci. 2024; 25(16).

PMID: 39201313 PMC: 11354650. DOI: 10.3390/ijms25168626.


Polyphenols: immunonutrients tipping the balance of immunometabolism in chronic diseases.

Ferreira C, Vieira P, Sa H, Malva J, Castelo-Branco M, Reis F Front Immunol. 2024; 15:1360065.

PMID: 38558823 PMC: 10978763. DOI: 10.3389/fimmu.2024.1360065.


The potential of therapeutic strategies targeting mitochondrial biogenesis for the treatment of insulin resistance and type 2 diabetes mellitus.

Ding W, Yang X, Lai K, Jiang Y, Liu Y Arch Pharm Res. 2024; 47(3):219-248.

PMID: 38485900 DOI: 10.1007/s12272-024-01490-5.


References
1.
Drexler H, Riede U, Munzel T, Konig H, Funke E, Just H . Alterations of skeletal muscle in chronic heart failure. Circulation. 1992; 85(5):1751-9. DOI: 10.1161/01.cir.85.5.1751. View

2.
Nisoli E, Clementi E, Carruba M, Moncada S . Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome?. Circ Res. 2007; 100(6):795-806. DOI: 10.1161/01.RES.0000259591.97107.6c. View

3.
Keteyian S, Fleg J, Brawner C, Pina I . Role and benefits of exercise in the management of patients with heart failure. Heart Fail Rev. 2010; 15(6):523-30. DOI: 10.1007/s10741-009-9157-7. View

4.
Nielsen J, Mogensen M, Vind B, Sahlin K, Hojlund K, Schroder H . Increased subsarcolemmal lipids in type 2 diabetes: effect of training on localization of lipids, mitochondria, and glycogen in sedentary human skeletal muscle. Am J Physiol Endocrinol Metab. 2009; 298(3):E706-13. DOI: 10.1152/ajpendo.00692.2009. View

5.
Chomentowski P, Coen P, Radikova Z, Goodpaster B, Toledo F . Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility. J Clin Endocrinol Metab. 2010; 96(2):494-503. PMC: 3048328. DOI: 10.1210/jc.2010-0822. View